World Equity Group, Inc. Astrazeneca PLC Transaction History

World Equity Group, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jul 22, 2024	SELL	$61.89 - $69.28 $11,759 - $13,163	-190 Reduced 4.08%	4,472 $301 Million
Q3 2023 Jul 22, 2024	BUY	$64.85 - $71.7 $302,330 - $334,265	4,662 New	4,662 $316 Million
Q2 2022 Sep 06, 2024	SELL	$59.26 - $71.14 $3,259 - $3,912	-55 Reduced 1.77%	3,046 $201 Million
Q1 2022 Sep 06, 2024	BUY	$55.72 - $67.12 $172,787 - $208,139	3,101 New	3,101 $206 Million

1,334

476M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $218B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of World Equity Group, Inc., based on Form 13F filings with the SEC.

Stay updated on World Equity Group, Inc. with notifications on news.